A new bioinformatics approach identifies overexpression of GRB2 as a poor prognostic biomarker for prostate cancer
Abstract A subset of prostate cancer displays a poor clinical outcome. Therefore, identifying this poor prognostic subset within clinically aggressive groups (defined as a Gleason score (GS) ≧8) and developing effective treatments are essential if we are to improve prostate cancer survival. Here, we...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/57ba76a682034c09bcdb46e58c83ae0b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|